Effects of Aerobic and Resistance Exercise on Cardiovascular Biomarkers in Sedentary Women
1 other identifier
interventional
45
1 country
1
Brief Summary
This randomized controlled trial investigated the effects of aerobic and resistance exercise on cardiovascular and inflammatory biomarkers in sedentary young women. Forty-five healthy sedentary females aged 18 to 25 years were randomly assigned to aerobic exercise, resistance exercise, or control groups. The exercise groups trained three times per week for 8 weeks under supervision, while the control group maintained a sedentary lifestyle. Blood samples and physiological measurements were obtained at baseline and after the intervention. The primary aim was to evaluate changes in circulating natriuretic peptides and inflammatory biomarkers, including NT-proBNP, BNP, soluble ST2, and Galectin-3. Secondary outcomes included lipid profile, glucose and insulin levels, blood pressure, and aerobic fitness. The study examined whether different exercise modalities induce beneficial cardiometabolic adaptations in previously sedentary young women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 23, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2025
CompletedFirst Submitted
Initial submission to the registry
January 31, 2026
CompletedFirst Posted
Study publicly available on registry
March 9, 2026
CompletedMarch 9, 2026
March 1, 2026
10 months
January 31, 2026
March 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Serum NT-proBNP Level
Difference in fasting serum N-terminal pro-brain natriuretic peptide (NT-proBNP) concentration between baseline and after 8 weeks of intervention.
Baseline and Week 8
Study Arms (3)
Aerobic Exercise
EXPERIMENTALParticipants performed supervised moderate-intensity aerobic exercise on a treadmill (walking and jogging) at 60-75% of heart rate reserve, 60 minutes per session, three times per week for 8 weeks.
Resistance Exercise
EXPERIMENTALParticipants performed supervised whole-body resistance training consisting of major upper and lower body exercises, 3 sets of 8-10 repetitions at approximately 70-80% of one-repetition maximum, three times per week for 8 weeks.
Resistance Training
NO INTERVENTIONParticipants maintained their habitual sedentary lifestyle and did not participate in any structured exercise program for 8 weeks.
Interventions
Supervised treadmill-based moderate-intensity walking and jogging at 60-75% of heart rate reserve, 60 minutes per session including warm-up and cool-down, three sessions per week for 8 weeks.
Supervised whole-body resistance training including major muscle group exercises, performed as 3 sets of 8-10 repetitions at approximately 70-80% of one-repetition maximum, three sessions per week for 8 weeks.
Eligibility Criteria
You may qualify if:
- Female, aged 18 to 25 years
- Sedentary lifestyle (no regular structured exercise training)
- Apparently healthy with no diagnosed cardiovascular, metabolic, or inflammatory disease
- Willing to participate in an 8-week supervised exercise program and provide blood samples
- Provided written informed consent
You may not qualify if:
- History of cardiovascular disease, diabetes mellitus, or chronic inflammatory disorder
- Current use of medications affecting cardiovascular or metabolic function
- Regular participation in structured exercise or competitive sports
- Smoking or alcohol/drug abuse
- Any musculoskeletal or medical condition that prevents safe participation in exercise
- Pregnancy or suspected pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara University
Ankara, Besevler, 06100, Turkey (Türkiye)
Related Publications (3)
Schmitt VH, Prochaska JH, Foll AS, Schulz A, Keller K, Hahad O, Koeck T, Trobs SO, Rapp S, Beutel M, Pfeiffer N, Strauch K, Lackner KJ, Munzel T, Wild PS. Galectin-3 for prediction of cardiac function compared to NT-proBNP in individuals with prediabetes and type 2 diabetes mellitus. Sci Rep. 2021 Sep 24;11(1):19012. doi: 10.1038/s41598-021-98227-x.
PMID: 34561496BACKGROUNDLavie CJ, Ozemek C, Carbone S, Katzmarzyk PT, Blair SN. Sedentary Behavior, Exercise, and Cardiovascular Health. Circ Res. 2019 Mar;124(5):799-815. doi: 10.1161/CIRCRESAHA.118.312669.
PMID: 30817262BACKGROUNDRukavina Mikusic NL, Kouyoumdzian NM, Puyo AM, Fernandez BE, Choi MR. Role of natriuretic peptides in the cardiovascular-adipose communication: a tale of two organs. Pflugers Arch. 2022 Jan;474(1):5-19. doi: 10.1007/s00424-021-02596-1. Epub 2021 Jun 26.
PMID: 34173888BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Sports Sciences
Study Record Dates
First Submitted
January 31, 2026
First Posted
March 9, 2026
Study Start
January 22, 2023
Primary Completion
November 23, 2023
Study Completion
May 1, 2025
Last Updated
March 9, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
Individual participant data will be shared upon reasonable request to the corresponding author and after approval by the research team and ethics requirements.